Healthcare innovation in South Africa
The imminent release of the findings of the
Competition Commission health-market inquiry and the consequent drive to uniform
tariffs, as well as the imminent National Health Insurance NHI rollout, continued consolidation of
medical aids and finally the inextricable rise in medial inflation, culminate
in a perfect storm for the sector. Against this backdrop of healthcare reform, medical technology companies are focused more than ever on products that deliver cheaper, faster, more efficient patient care. How do re-imbursement models need to change to facilitate disruptive innovation?
rollout and its impact on the healthcare landscape;
Healthcare innovation in South Africa: hospitals, medical
schemes, primary care markets;
public partnerships: private care involvement in the NHI;
the pharma-care landscape: technology and biotechnology infrastructure,
the pharmaceutical value chain, access to world-class generics and
Innovation in health financing and health delivery;
through blockchain: healthcare on the blockchain
means a whole lot more than streamlined hospital visits;
Venture capital and innovation: what is the state of the
healthcare start-up arena? What funding is available? What role does VC
and PE play?;
and operating models;
Innovation in medical devices and other technology: against the backdrop of
healthcare reform, medical technology companies are focused more than ever on
products that deliver cheaper, faster, more efficient patient care. How do re-imbursement models need to change to
facilitate disruptive innovation?
Speakers confirmed to date:
Click here for programme agenda.
Discounts of 20% for bookings of five and more.